Quantum dots in brain could treat Parkinson’s and Alzheimer’s diseases

Tiny particles called quantum dots reduce symptoms in mice primed to develop a type of Parkinson’s disease, and also block formation of the toxic protein clumps in Alzheimer’s. One day they could be a novel treatment for these brain disorders, although tests in people are some years away.

Quantum dots are just a few nanometres in size – so small they become subject to some of the strange effects of quantum physics. They have useful electronic and fluorescent properties and are found in some TV screens and LED lights.

Nanoco (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy-metal free quantum dots and semiconductor nanoparticles for use in displays, lighting, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical